CFMATTERS was the first randomized, controlled trial comparing the use of microbiome-directed antibiotic treatment versus standard therapy for patients with CF experiencing respiratory infections. The trial was coordinated by Prof. Barry Plant, University College Cork in Ireland and received funding from the European Union under the 7th framework programme.